FDA seeks feedback on regulating generative AI-enabled medical devices
emmanuelvivier · x · 2026-08-30
The FDA's Digital Health Center of Excellence released a discussion paper requesting feedback on the regulation of generative AI-enabled medical devices. The paper addresses the unique risks posed by GenAI in healthcare and seeks to advance regulatory approaches, covering topics such as risk assessment, premarket evaluation, and postmarket surveillance.
More from Safety
- Google Paper: Autonomous AI Research Hallucinates 90% Without Checks — rohanpaul_ai · 2026-09-01
- On token layers and consciousness in RLHF — voooooogel · 2026-09-01
- Agents can't verify people: data enrichment APIs are failing — Dry_Steak30 · 2026-09-01
- Deploying models requires tapping into different reward expectations — FioraStarlight · 2026-09-01
- Open Source Resource for Model Distillation Attacks Shared — k7agar · 2026-09-01
- Technical Critique of OpenAI Safety Report: SSRF Flaw and Anthropomorphism — AlexTensor · 2026-09-01